HCPCS Level IIdrugActive
J2508
Pegunigalsidase alfa-iwxj
BETOS: O1E
Effective: 2024-01-01
Description
Injection, pegunigalsidase alfa-iwxj, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Elfabrio
Manufacturer
Chiesi USA, Inc.
HCPCS Dosage
1 MG
Billing Units
20.0000
4
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.